Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| TZYM Historical Stock Prices |
| Preferred Stock Newsletter |
| Top Option Ideas |
| Stock Message Boards |
TZYM (TZYM) has the following price history information. Looking back at TZYM historical stock prices for the last five trading days, on July 09, 2013, TZYM opened at $0.54, traded as high as $0.54 and as low as $0.49, and closed at $0.53. Trading volume was a total of 38.80K shares. On July 10, 2013, TZYM opened at $0.54, traded as high as $0.54 and as low as $0.49, and closed at $0.50. Trading volume was a total of 88.20K shares. On July 11, 2013, TZYM opened at $0.49, traded as high as $0.51 and as low as $0.45, and closed at $0.49. Trading volume was a total of 38.50K shares. On July 12, 2013, TZYM opened at $0.47, traded as high as $0.51 and as low as $0.47, and closed at $0.51. Trading volume was a total of 15.00K shares. On July 15, 2013, TZYM opened at $0.48, traded as high as $0.50 and as low as $0.47, and closed at $0.48. Trading volume was a total of 126.70K shares.
TZYM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into TZYM shares, starting with a $10,000 purchase of TZYM, and working forward through the historical stock price information to today. TZYM -- use the split history when considering split-adjusted past price performance.
 | |||||
| TZYM Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 07/09/2013 | $0.54 | $0.54 | $0.49 | $0.53 | 38.80K |
| 07/10/2013 | $0.54 | $0.54 | $0.49 | $0.50 | 88.20K |
| 07/11/2013 | $0.49 | $0.51 | $0.45 | $0.49 | 38.50K |
| 07/12/2013 | $0.47 | $0.51 | $0.47 | $0.51 | 15.00K |
| 07/15/2013 | $0.48 | $0.50 | $0.47 | $0.48 | 126.70K |
|
| About TZYM |
| Tranzyme is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing small molecule therapeutics for the treatment of gastrointestinal (GI) motility disorders in the acute (hospital-based) and chronic settings. Co.'s two clinical stage product candidates, ulimorelin, an intravenous ghrelin, and TZP-102, an orally administered ghrelin agonist, target the ghrelin receptor, a mechanism of action with a potent and direct role in the stimulation of GI motility. Co. is also developing a motilin antagonist, TZP-201, for the treatment of various forms of moderate-to-severe diarrhea, and a ghrelin antagonist, TZP-301, for the treatment of metabolic diseases. |
| TZYM Historical Closing Prices | |
| Date | Close |
| 07/09/2013 | $0.53 |
| 07/10/2013 | $0.50 |
| 07/11/2013 | $0.49 |
| 07/12/2013 | $0.51 |
| 07/15/2013 | $0.48 |
| Healthcare Historical Prices |
| TZYM is categorized under the Healthcare sector; below are some other companies in the same sector:
UHS Historical Stock Prices
|
Free TZYM Email Alerts:
TZYM Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.